
IDGXF
Healthcare · Diagnostics & Research · $349.4M market cap
$0.6010+0.13 (+27.9%)Nov 13, 2:33 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Mar 31, 2024
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 29, 2024 | Before the open | — | 0.00 | — |
| May 30, 2024 | Before the open | — | 0.02 | — |
| Mar 28, 2024 | Before the open | — | 0.01 | — |
| Nov 16, 2022 | After the close | — | -0.00 | — |
| Sep 11, 2022 | After the close | — | 0.01 | — |
| Jun 7, 2022 | After the close | — | 0.03 | — |
| Nov 15, 2021 | After the close | — | 0.05 | — |
| Sep 1, 2021 | After the close | 0.00 | 0.05 | — |
| Jun 1, 2021 | After the close | 0.00 | 0.03 | — |
| Mar 31, 2021 | Time not confirmed | 0.00 | 0.03 | — |
| Nov 18, 2020 | After the close | 0.00 | 0.02 | — |
| Sep 1, 2020 | After the close | 0.00 | 0.02 | — |
| Apr 27, 2020 | After the close | 0.00 | 0.01 | — |
| Mar 31, 2020 |
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed…
| Time not confirmed |
| 0.00 |
| 0.01 |
| — |
| Nov 26, 2019 | After the close | 0.00 | 0.02 | — |
| Sep 9, 2019 | After the close | 0.00 | 0.01 | — |
| May 14, 2019 | After the close | 0.00 | 0.01 | — |
| Nov 20, 2018 | After the close | 0.00 | 0.01 | — |
| Aug 15, 2018 | After the close | 0.00 | 0.01 | — |
| Jun 30, 2018 | Time not confirmed | 0.00 | 0.01 | — |
| Mar 20, 2018 | After the close | 0.00 | 0.01 | — |